ArticleFrontiers in immunology2022

The survival outcomes of neoadjuvant sintilimab combined with chemotherapy in patients with locally advanced esophageal squamous cell carcinoma.

Huilai Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.